INX-315 is an oral, investigational selective cyclin-dependent kinase 2 (CDK2) inhibitor. The designation was based on preclinical data as well as interim data from the ongoing phase 1/2 INX-315-01 ...

The phase 3 trial enrolled 1033 patients who had not received prior chemotherapy for mCRPC and had evidence of disease progression despite androgen deprivation therapy.

Nipocalimab-aahu is a human immunoglobulin G1 monoclonal antibody that binds with high affinity to the neonatal Fc receptor, resulting in the reduction of circulating IgG levels.

The Food and Drug Administration (FDA) has granted Fast Track designation to bempikibart for the treatment of alopecia areata (AA).

Neoadjuvant PD-1 blockade with dostarlimab enables nonoperative management strategy for large proportion of patients.

HealthDay News — An intensive blood pressure (BP) reduction intervention is effective for lowering the risk for all-cause dementia among individuals aged 40 years and older with untreated hypertension ...

Increase seen in lifetime use among adults and adolescents; past-year use higher among young adults, older adults.

Outbreak mainly affected members of communities with low measles vaccination coverage in New Mexico, Oklahoma, and Texas.

For children with sickle cell anemia (SCA), hydroxyurea has sustained clinical benefits in terms of reducing emergency department visits and hospital days, acco ...

Older patients have divergent immune phenotypes at baseline that persist during immune checkpoint inhibitor therapy.

At Sensient Technologies, one of the world’s largest dyemakers, scientists are working hard to find natural alternatives.

NIH Director Dr Jay Bhattacharya previously announced plans to develop "national disease registries, including a new one for autism" as part of a larger research effort.